Connecticut Requires Pharmaceutical and Device Companies to Report Payments and Transfers of Value Made To Nurse Practitioners and other APRNs

For the first time in five years a state has passed legislation aimed at reporting payments from pharmaceutical and device manufacturers to healthcare providers. Starting October 2014, Connecticut will require pharmaceutical and device manufacturers to report payments and transfers of value to advance practice registered nurses (APRNs). This group includes nurse practitioners, clinical nurse specialists, nurse anesthetists, and nurse midwives. APRNs are excluded from the reporting obligations under the Federal Physician Payments Sunshine Act. The disclosure requirement is part of a new law in Connecticut that allows APRNs to practice independent of physicians. -

See more at: http://www.policymed.com/2014/05/connecticut-to-require-pharmaceutical-and-device-companies-to-report-payments-andtransfers-of-value-made-to-nurse-practitione.html#sthash.jsaNeqWZ.dpuf